{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T23:42:20Z","timestamp":1774914140991,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,8,30]],"date-time":"2010-08-30T00:00:00Z","timestamp":1283126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,8,30]],"date-time":"2010-08-30T00:00:00Z","timestamp":1283126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2011,1,6]]},"DOI":"10.1038\/onc.2010.395","type":"journal-article","created":{"date-parts":[[2010,8,30]],"date-time":"2010-08-30T11:31:45Z","timestamp":1283167905000},"page":"21-31","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Hypoxia and cell cycle regulation of the von Hippel\u2013Lindau tumor suppressor"],"prefix":"10.1038","volume":"30","author":[{"given":"W","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Xin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D T","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J A","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J R","family":"Gnarra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,8,30]]},"reference":[{"key":"BFonc2010395_CR1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00018-007-6443-1","volume":"64","author":"DJ Baker","year":"2007","unstructured":"Baker DJ, Dawlaty MM, Galardy P, van Deursen JM . (2007). Mitotic regulation of the anaphase-promoting complex. Cell Mol Life Sci 64: 589\u2013600.","journal-title":"Cell Mol Life Sci"},{"key":"BFonc2010395_CR2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/(SICI)1098-1004(200001)15:1<86::AID-HUMU16>3.0.CO;2-4","volume":"15","author":"C Beroud","year":"2000","unstructured":"Beroud C, Collod-Beroud G, Boileau C, Soussi T, Junien C . (2000). UMD (universal mutation database): a generic software to build and analyze locus-specific databases. Hum Mutat 15: 86\u201394.","journal-title":"Hum Mutat"},{"key":"BFonc2010395_CR3","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1371\/journal.pmed.0030047","volume":"3","author":"JT Chi","year":"2006","unstructured":"Chi JT, Wang Z, Nuyten DS, Rodriguez EH, Schaner ME, Salim A et al. (2006). Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers. PLoS Med 3: e47.","journal-title":"PLoS Med"},{"key":"BFonc2010395_CR4","first-page":"1387","volume":"98","author":"N de Paulsen","year":"2001","unstructured":"de Paulsen N, Brychzy A, Fournier MC, Klausner RD, Gnarra JR, Pause A et al. (2001). Role of transforming growth factor-alpha in von Hippel--Lindau (VHL)(-\/-) clear cell renal carcinoma cell proliferation: a possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis. Proc Natl Acad Sci USA 98: 1387\u20131392.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2010395_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1146\/annurev.biochem.78.101807.093809","volume":"78","author":"RJ Deshaies","year":"2009","unstructured":"Deshaies RJ, Joazeiro CA . (2009). RING domain E3 ubiquitin ligases. Annu Rev Biochem 78: 399\u2013434.","journal-title":"Annu Rev Biochem"},{"key":"BFonc2010395_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1748-1716.2008.01894.x","volume":"195","author":"M F\u00e4hling","year":"2009","unstructured":"F\u00e4hling M . (2009). Cellular oxygen sensing, signalling and how to survive translational arrest in hypoxia. Acta Physiologica 195: 205\u2013230.","journal-title":"Acta Physiologica"},{"key":"BFonc2010395_CR7","doi-asserted-by":"publisher","first-page":"7919","DOI":"10.1074\/jbc.M010189200","volume":"276","author":"LB Gardner","year":"2001","unstructured":"Gardner LB, Li Q, Park MS, Flanagan WM, Semenza GL, Dang CV . (2001). Hypoxia inhibits G1\/S transition through regulation of p27 expression. J Biol Chem 276: 7919\u20137926.","journal-title":"J Biol Chem"},{"key":"BFonc2010395_CR8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ccr.2007.02.006","volume":"11","author":"JD Gordan","year":"2007","unstructured":"Gordan JD, Bertout JA, Hu CJ, Diehl JA, Simon MC . (2007). HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell 11: 335\u2013347.","journal-title":"Cancer Cell"},{"key":"BFonc2010395_CR9","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.4161\/cc.8.9.8306","volume":"8","author":"T Hackenbeck","year":"2009","unstructured":"Hackenbeck T, Knaup KX, Schietke R, Sch\u00f6del J, Willam C, Wu X et al. (2009). HIF-1 or HIF-2 induction is sufficient to achieve cell cycle arrest in NIH3T3 mouse fibroblasts independent from hypoxia. Cell Cycle 8: 1386\u20131395.","journal-title":"Cell Cycle"},{"key":"BFonc2010395_CR10","first-page":"157","volume":"296","author":"JV Harper","year":"2005","unstructured":"Harper JV . (2005). Synchronization of cell populations in G1\/S and G2\/M phases of the cell cycle. Methods Mol Biol 296: 157\u2013166.","journal-title":"Methods Mol Biol"},{"key":"BFonc2010395_CR11","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/ncb899","volume":"5","author":"A Hergovich","year":"2003","unstructured":"Hergovich A, Lisztwan J, Barry R, Ballschmieter P, Krek W . (2003). Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL. Nat Cell Biol 5: 64\u201370.","journal-title":"Nat Cell Biol"},{"key":"BFonc2010395_CR12","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nm0895-822","volume":"1","author":"O Iliopoulos","year":"1995","unstructured":"Iliopoulos O, Kibel A, Gray S, Kaelin WG . (1995). Tumor suppression by the human von Hippel-Lindau gene product. Nat Med 1: 822\u2013826.","journal-title":"Nat Med"},{"key":"BFonc2010395_CR13","doi-asserted-by":"publisher","first-page":"11661","DOI":"10.1073\/pnas.95.20.11661","volume":"95","author":"O Iliopoulos","year":"1998","unstructured":"Iliopoulos O, Ohh M, Kaelin Jr WG . (1998). pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation. Proc Natl Acad Sci USA 95: 11661\u201311666.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2010395_CR14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.tcb.2004.05.005","volume":"14","author":"PK Jackson","year":"2004","unstructured":"Jackson PK . (2004). Linking tumor suppression, DNA damage and the anaphase-promoting complex. Trends Cell Biol 14: 331\u2013334.","journal-title":"Trends Cell Biol"},{"key":"BFonc2010395_CR15","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/nm1440","volume":"12","author":"CR Jung","year":"2006","unstructured":"Jung CR, Hwang KS, Yoo J, Cho WK, Kim JM, Kim WH et al. (2006). E2-EPF UCP targets pVHL for degradation and associates with tumor growth and metastasis. Nat Med 12: 809\u2013816.","journal-title":"Nat Med"},{"key":"BFonc2010395_CR16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1146\/annurev.biochem.74.082803.133142","volume":"74","author":"WG Kaelin","year":"2005","unstructured":"Kaelin WG . (2005). Proline hydroxylation and gene expression. Annu Rev Biochem 74: 115\u2013128.","journal-title":"Annu Rev Biochem"},{"key":"BFonc2010395_CR17","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev.pathol.2.010506.092049","volume":"2","author":"WG Kaelin","year":"2007","unstructured":"Kaelin WG . (2007a). Von Hippel-Lindau disease. Annu Rev Pathol 2: 145\u2013173.","journal-title":"Annu Rev Pathol"},{"key":"BFonc2010395_CR18","doi-asserted-by":"publisher","first-page":"680s","DOI":"10.1158\/1078-0432.CCR-06-1865","volume":"13","author":"WG Kaelin Jr","year":"2007","unstructured":"Kaelin Jr WG . (2007b). The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma. Clin Cancer Res 13: 680s\u2013684s.","journal-title":"Clin Cancer Res"},{"key":"BFonc2010395_CR19","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/nrc2502","volume":"8","author":"WG Kaelin Jr","year":"2008","unstructured":"Kaelin Jr WG . (2008). The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer. Nat Rev Cancer 8: 865\u2013873.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2010395_CR20","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1038\/sj.emboj.7600196","volume":"23","author":"M Koshiji","year":"2004","unstructured":"Koshiji M, Kageyama Y, Pete EA, Horikawa I, Barrett JC, Huang LE . (2004). HIF-1alpha induces cell cycle arrest by functionally counteracting Myc. EMBO J 23: 1949\u20131956.","journal-title":"EMBO J"},{"key":"BFonc2010395_CR21","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/nrg2665","volume":"10","author":"U Lendahl","year":"2009","unstructured":"Lendahl U, Lee KL, Yang H, Poellinger L . (2009). Generating specificity and diversity in the transcriptional response to hypoxia. Nat Rev Genet 10: 821\u2013832.","journal-title":"Nat Rev Genet"},{"key":"BFonc2010395_CR22","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/sj.emboj.7600149","volume":"23","author":"T Listovsky","year":"2004","unstructured":"Listovsky T, Oren YS, Yudkovsky Y, Mahbubani HM, Weiss AM, Lebendiker M et al. (2004). Mammalian Cdh1\/Fzr mediates its own degradation. EMBO J 23: 1619\u20131626.","journal-title":"EMBO J"},{"key":"BFonc2010395_CR23","doi-asserted-by":"publisher","first-page":"492","DOI":"10.4161\/cbt.3.6.1010","volume":"3","author":"L Liu","year":"2004","unstructured":"Liu L, Simon MC . (2004). Regulation of transcription and translation by hypoxia. Cancer Biol Ther 3: 492\u2013497.","journal-title":"Cancer Biol Ther"},{"key":"BFonc2010395_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/carcin\/bgm251","volume":"29","author":"W Liu","year":"2008","unstructured":"Liu W, Li W, Fujita T, Yang Q, Wan Y . (2008). Proteolysis of CDH1 enhances susceptibility to UV radiation-induced apoptosis. Carcinogenesis 29: 263\u2013272.","journal-title":"Carcinogenesis"},{"key":"BFonc2010395_CR25","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1128\/MCB.01830-06","volume":"27","author":"W Liu","year":"2007","unstructured":"Liu W, Wu G, Li W, Lobur D, Wan Y . (2007). Cdh1-anaphase-promoting complex targets Skp2 for destruction in transforming growth factor beta-induced growth inhibition. Mol Cell Biol 27: 2967\u20132979.","journal-title":"Mol Cell Biol"},{"key":"BFonc2010395_CR26","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nrm2163","volume":"8","author":"A Musacchio","year":"2007","unstructured":"Musacchio A, Salmon ED . (2007). The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol 8: 379\u2013393.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc2010395_CR27","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1073\/pnas.95.3.993","volume":"95","author":"A Pause","year":"1998","unstructured":"Pause A, Lee S, Lonergan KM, Klausner RD . (1998). The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal. Proc Natl Acad Sci USA 95: 993\u2013998.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2010395_CR28","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1101\/gad.918201","volume":"15","author":"CM Pfleger","year":"2001","unstructured":"Pfleger CM, Lee E, Kirschner MW . (2001). Substrate recognition by the Cdc20 and Cdh1 components of the anaphase-promoting complex. Genes Dev 15: 2396\u20132407.","journal-title":"Genes Dev"},{"key":"BFonc2010395_CR29","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1128\/MCB.18.5.2845","volume":"18","author":"C Schmaltz","year":"1998","unstructured":"Schmaltz C, Hardenbergh PH, Wells A, Fisher DE . (1998). Regulation of proliferation-survival decisions during tumor cell hypoxia. Mol Cell Biol 18: 2845\u20132854.","journal-title":"Mol Cell Biol"},{"key":"BFonc2010395_CR30","doi-asserted-by":"publisher","first-page":"8817","DOI":"10.1073\/pnas.95.15.8817","volume":"95","author":"A Schoenfeld","year":"1998","unstructured":"Schoenfeld A, Davidowitz EJ, Burk RD . (1998). A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor. Proc Natl Acad Sci USA 95: 8817\u20138822.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2010395_CR31","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1182\/blood-2009-05-189985","volume":"114","author":"GL Semenza","year":"2009","unstructured":"Semenza GL . (2009). Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis. Blood 114: 2015\u20132019.","journal-title":"Blood"},{"key":"BFonc2010395_CR32","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1126\/science.284.5413.455","volume":"284","author":"CE Stebbins","year":"1999","unstructured":"Stebbins CE, Kaelin Jr WG, Pavletich NP . (1999). Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. Science 284: 455\u2013461.","journal-title":"Science"},{"key":"BFonc2010395_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.mrfmmm.2005.02.016","volume":"578","author":"NH Stickle","year":"2005","unstructured":"Stickle NH, Cheng LS, Watson IR, Alon N, Malkin D, Irwin MS et al. (2005). Expression of p53 in renal carcinoma cells is independent of pVHL. Mut Res 578: 23\u201332.","journal-title":"Mut Res"},{"key":"BFonc2010395_CR34","doi-asserted-by":"publisher","first-page":"6499","DOI":"10.1093\/emboj\/20.22.6499","volume":"20","author":"T Sudo","year":"2001","unstructured":"Sudo T, Ota Y, Kotani S, Nakao M, Takami Y, Takeda S et al. (2001). Activation of Cdh1-dependent APC is required for G1 cell cycle arrest and DNA damage-induced G2 checkpoint in vertebrate cells. EMBO J 20: 6499\u20136508.","journal-title":"EMBO J"},{"key":"BFonc2010395_CR35","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/ncb1579","volume":"9","author":"CR Thoma","year":"2007","unstructured":"Thoma CR, Frew IJ, Hoerner CR, Montani M, Moch H, Krek W . (2007). pVHL and GSK3beta are components of a primary cilium-maintenance signalling network. Nat Cell Biol 9: 588\u2013595.","journal-title":"Nat Cell Biol"},{"key":"BFonc2010395_CR36","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/ncb1912","volume":"11","author":"CR Thoma","year":"2009","unstructured":"Thoma CR, Toso A, Gutbrodt KL, Reggi SP, Frew IJ, Schraml P et al. (2009). VHL loss causes spindle misorientation and chromosome instability. Nat Cell Biol 11: 994\u20131001.","journal-title":"Nat Cell Biol"},{"key":"BFonc2010395_CR37","first-page":"49","volume":"1786","author":"R van Leuken","year":"2008","unstructured":"van Leuken R, Clijsters L, Wolthuis R . (2008). To cell cycle, swing the APC\/C. Biochimica et Biophysica Acta 1786: 49\u201359.","journal-title":"Biochimica et Biophysica Acta"},{"key":"BFonc2010395_CR38","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S1097-2765(01)00382-3","volume":"8","author":"Y Wan","year":"2001","unstructured":"Wan Y, Liu X, Kirschner MW . (2001). The anaphase-promoting complex mediates TGF-beta signaling by targeting SnoN for destruction. Mol Cell 8: 1027\u20131039.","journal-title":"Mol Cell"},{"key":"BFonc2010395_CR39","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1016\/j.yexcr.2008.03.003","volume":"314","author":"C Warnecke","year":"2008","unstructured":"Warnecke C, Weidemann A, Volke M, Schietke R, Wu X, Knaup KX et al. (2008). The specific contribution of hypoxia-inducible factor-2alpha to hypoxic gene expression in vitro is limited and modulated by cell type-specific and exogenous factors. Exp Cell Res 314: 2016\u20132027.","journal-title":"Exp Cell Res"},{"key":"BFonc2010395_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/onc.2009.325","volume":"29","author":"R Wasch","year":"2010","unstructured":"Wasch R, Robbins JA, Cross FR . (2010). The emerging role of APC\/C(Cdh1) in controlling differentiation, genomic stability and tumor suppression. Oncogene 29: 1\u201310.","journal-title":"Oncogene"},{"key":"BFonc2010395_CR41","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nature02381","volume":"428","author":"W Wei","year":"2004","unstructured":"Wei W, Ayad NG, Wan Y, Zhang GJ, Kirschner MW, Kaelin Jr WG . (2004). Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex. Nature 428: 194\u2013198.","journal-title":"Nature"},{"key":"BFonc2010395_CR42","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/sj.bjc.6601657","volume":"90","author":"CC Wykoff","year":"2004","unstructured":"Wykoff CC, Sotiriou C, Cockman ME, Ratcliffe PJ, Maxwell P, Liu E et al. (2004). Gene array of VHL mutation and hypoxia shows novel hypoxia-induced genes and that cyclin D1 is a VHL target gene. Br J Cancer 90: 1235\u20131243.","journal-title":"Br J Cancer"},{"key":"BFonc2010395_CR43","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/ncb1699","volume":"10","author":"AP Young","year":"2008","unstructured":"Young AP, Schlisio S, Minamishima YA, Zhang Q, Li L, Grisanzio C et al. (2008). VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400. Nat Cell Biol 10: 361\u2013369.","journal-title":"Nat Cell Biol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2010395.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2010395","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2010395.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T17:40:48Z","timestamp":1647884448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2010395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,30]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1,6]]}},"alternative-id":["BFonc2010395"],"URL":"https:\/\/doi.org\/10.1038\/onc.2010.395","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,30]]},"assertion":[{"value":"9 December 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}